Dr. Jacob Hanna — Synthetic embryo R&D in Regenerative Medicine and Developmental Biology
(https://hannalabweb.weizmann.ac.il/) is a Senior Scientist and Professor in the Department of Molecular Genetics at the Weizmann Institute of Science in Israel, where his lab, and the interdisciplinary group of scientists within it, are focused on understanding the complexity of early embryonic stem cell biology and early developmental dynamics, as well as advancing human disease modeling.
In particular, Dr. Hanna’s lab examines the process of cellular reprograming in which induced pluripotent stem cells are created from somatic cell, and how pluripotency in mice and humans is maintained. They use a variety of methods to answer biological questions, including high-throughput screening, advanced microscopic techniques, and genomic analyses.
Dr. Hanna earned both his MD degree and his PhD from The Hebrew University of Jerusalem. His work focused on immunology, with a thesis that focused on the novel molecular properties and functional characteristics of human NK Subsets. Then, he went on to complete postdoctoral research at the Whitehead Institute for Biomedical Research in MIT with Prof. Dr. Rudolf Jaenisch. His field of study was pluripotency.
Dr. Hanna is also Founder and Chief Scientific Advisor, of Renewal Bio (https://www.renewal.bio/), a biotech company looking to leverage the power of these new stem cell technologies, potentially applying them to a wide variety of human ailments including infertility, genetic diseases, and longevity.